Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients : Treatment of Acute Respiratory Syndrome Resulting From the Inflammatory Process of COVID-19 Infection Using Methotrexate-loaded Nanoparticles: A Phase I/II Study

The aim of this study is to evaluate the efficacy and safety of MTX-loaded nanoparticles in three different doses to treat severe COVID-19 patients..

Medienart:

Klinische Studie

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

ClinicalTrials.gov - (2020) vom: 29. Apr. Zur Gesamtaufnahme - year:2020

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: COVID-19
Phase: Phase 1/Phase 2
Recruitment Status: Not yet recruiting
Study Type: Interventional

Anmerkungen:

Source: Link to the current ClinicalTrials.gov record., First posted: April 20, 2020, Last downloaded: ClinicalTrials.gov processed this data on June 14, 2021, Last updated: June 15, 2021

Study ID:

NCT04352465
LDE-MTX_COVID19

Veröffentlichungen zur Studie:

fisyears:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

CTG003364259